We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Patent Issued

4 Jul 2018 07:00

RNS Number : 5006T
AorTech International PLC
04 July 2018
 

 4 July 2018 

AorTech International plc 

("AorTech" or the "Company") 

  

New Patent Issued

 

AorTech is pleased to announce that the Brazilian Patent Office has recently granted Patent Number PI 0711694-2 entitled Biostable Gels. The invention relates to biostable gels, the processes for their preparation and their use in the manufacture and repair of biomaterials and medical devices or implants, in particular soft tissue implants such as breast implants.

 

Bill Brown, Chairman of AorTech said: "The issue of this patent further expands AorTech's patent portfolio, particularly in the area of breast implants. Brazil is one of the largest markets for breast enhancement outside of the USA and is therefore an important patent territory. The portfolio of IP relating to Breast Implants is not currently licensed by AorTech."

  

For further information contact: 

  

AorTech International plc Tel: +44 (0)7730 718296  

Bill Brown, Chairman  

  

Stockdale Securities Limited Tel: +44 (0)20 7601 6100  

Tom Griffiths/David Coaten  

  

About AorTech: 

  

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA and Japanese Ministry of Health approvals. 

  

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

 

In addition to the licensing of biostable polymers, AorTech is now developing medical devices utilizing the key properties of its world class polymers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLLFERDVIVIIT
Date   Source Headline
4th Apr 20084:20 pmRNSHolding(s) in Company
1st Apr 200812:16 pmRNSHolding(s) in Company
1st Apr 200812:07 pmRNSTotal Voting Rights
26th Mar 200812:53 pmRNSHolding(s) in Company
20th Mar 20087:01 amRNSLicence Deal
18th Mar 20087:00 amRNSMilestone Payment
10th Mar 20089:12 amRNSHolding(s) in Company
28th Feb 20082:02 pmRNSHolding(s) in Company
13th Feb 20084:31 pmRNSHolding(s) in Company
13th Feb 200810:11 amRNSHolding(s) in Company
7th Feb 20084:10 pmRNSHolding(s) in Company
13th Dec 20075:35 pmRNSAdditional Listing
13th Dec 20077:01 amRNSInterim Results
29th Nov 20074:52 pmRNSAllium Partnership
22nd Nov 20075:20 pmRNSHolding(s) in Company
23rd Oct 200710:06 amRNSHolding(s) in Company
23rd Oct 200710:04 amRNSHolding(s) in Company
9th Oct 20073:07 pmRNSAdditional Listing
2nd Oct 200711:14 amRNSResult of AGM
6th Sep 20077:01 amRNSFinal Results
4th Sep 200712:33 pmRNSNotice of Results
24th Aug 20074:10 pmRNSHolding(s) in Company
23rd Aug 20074:21 pmRNSHolding(s) in Company
23rd Aug 20074:19 pmRNSHolding(s) in Company
23rd Aug 20074:16 pmRNSHolding(s) in Company
23rd Aug 20073:30 pmRNSAIM Rule 26 Information
20th Aug 200712:28 pmRNSResult of EGM
9th Aug 200710:27 amRNSHolding(s) in Company
6th Aug 20076:03 pmRNSHolding in Company
6th Aug 20075:55 pmRNSHolding in Company
24th Jul 20077:01 amRNSDirector/PDMR Shareholding
24th Jul 20077:00 amRNSPlacing & Trading Update
11th Jul 20072:23 pmRNSHolding(s) in Company
9th Jul 20075:45 pmRNSHolding(s) in Company
27th Apr 200710:04 amRNSDirector/PDMR Shareholding
16th Apr 20073:16 pmRNSHolding(s) in Company
16th Apr 20073:15 pmRNSHolding(s) in Company
26th Jan 20073:58 pmRNSHolding(s) in Company
26th Jan 20073:56 pmRNSHolding(s) in Company
26th Jan 20079:13 amRNSHolding(s) in Company
13th Dec 20068:40 amRNSTotal Voting Rights
6th Dec 20067:03 amRNSSupply Agreement
6th Dec 20067:01 amRNSInterim Results
5th Dec 200612:31 pmRNSLicensing & Supply Agreement
30th Oct 20067:02 amRNSOpening of new facility
26th Oct 20067:01 amRNSPresentation at TCT Symposium
25th Oct 20067:02 amRNSSupply & License Agreement
24th Oct 20063:08 pmRNSHolding(s) in Company
11th Oct 200612:36 pmRNSHolding(s) in Company
28th Sep 20062:49 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.